Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.


Journal

Annals of oncology : official journal of the European Society for Medical Oncology
ISSN: 1569-8041
Titre abrégé: Ann Oncol
Pays: England
ID NLM: 9007735

Informations de publication

Date de publication:
01 11 2019
Historique:
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 9 7 2020
Statut: ppublish

Résumé

The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are encoded by NTRK genes and have a role in the development and normal functioning of the nervous system. Since the discovery of an oncogenic NTRK gene fusion in colorectal cancer in 1986, over 80 different fusion partner genes have been identified in a wide array of adult and paediatric tumours, providing actionable targets for targeted therapy. This review describes the normal function and physiology of TRK receptors and the biology behind NTRK gene fusions and how they act as oncogenic drivers in cancer. Finally, an overview of the incidence and prevalence of NTRK gene fusions in various types of cancers is discussed.

Identifiants

pubmed: 31738427
pii: S0923-7534(19)55117-1
doi: 10.1093/annonc/mdz383
pmc: PMC6859819
doi:
pii:

Substances chimiques

Oncogene Proteins, Fusion 0
Protein Kinases EC 2.7.-
Receptor Protein-Tyrosine Kinases EC 2.7.10.1
Receptor, trkA EC 2.7.10.1
tropomyosin kinase EC 2.7.11.28

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

viii5-viii15

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology.

Références

Oncotarget. 2015 Nov 17;6(36):39028-35
pubmed: 26472021
Cancer Res. 1998 Nov 15;58(22):5046-8
pubmed: 9823307
J Biol Chem. 1995 Sep 1;270(35):20384-90
pubmed: 7657612
Jpn J Cancer Res. 1992 Jul;83(7):671-5
pubmed: 1381340
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Cancer Discov. 2017 Apr;7(4):400-409
pubmed: 28183697
J Clin Pathol. 2018 Oct;71(10):926-931
pubmed: 29802225
Cell. 1991 May 31;65(5):895-903
pubmed: 1645620
Nat Commun. 2015 May 27;6:7174
pubmed: 26013381
J Pathol. 2016 Nov;240(3):282-290
pubmed: 27477320
Nat Commun. 2014;5:3116
pubmed: 24445538
Br J Cancer. 2000 Jan;82(2):308-14
pubmed: 10646882
Nat Commun. 2017 Jul 11;8:15987
pubmed: 28695888
Nat Med. 2013 Nov;19(11):1469-1472
pubmed: 24162815
Target Oncol. 2018 Oct;13(5):545-556
pubmed: 30276762
Oncotarget. 2017 Jun 20;8(25):39945-39962
pubmed: 28591715
Cell. 1994 Mar 25;76(6):1001-11
pubmed: 8137419
Genomics. 1995 Jan 20;25(2):538-46
pubmed: 7789988
JCO Precis Oncol. 2018;2018:
pubmed: 30215037
Clin Biochem. 1996 Jun;29(3):267-71
pubmed: 8740514
Nat Genet. 2014 May;46(5):444-450
pubmed: 24705251
Cancer Lett. 2015 Aug 28;365(1):107-11
pubmed: 26001971
Cancer Lett. 2001 Aug 28;169(2):107-14
pubmed: 11431098
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11133-7
pubmed: 7972023
J Neurobiol. 1994 Nov;25(11):1386-403
pubmed: 7852993
Nature. 1994 Mar 17;368(6468):246-9
pubmed: 8145823
J Clin Invest. 2013 Nov;123(11):4935-44
pubmed: 24135138
Mod Pathol. 2018 Mar;31(3):463-473
pubmed: 29099503
Cell. 1991 Jul 12;66(1):173-83
pubmed: 1649007
Histopathology. 2016 Jul;69(1):72-83
pubmed: 26647767
Oncogene. 1992 Feb;7(2):237-42
pubmed: 1532241
Nat Genet. 1998 Feb;18(2):184-7
pubmed: 9462753
Nat Genet. 2013 Aug;45(8):927-32
pubmed: 23817572
Neuron. 1996 Dec;17(6):1065-78
pubmed: 8982156
EMBO J. 1998 Dec 15;17(24):7282-93
pubmed: 9857185
Nat Genet. 2013 Oct;45(10):1141-9
pubmed: 23917401
CNS Neurol Disord Drug Targets. 2008 Feb;7(1):46-62
pubmed: 18289031
Mol Oncol. 2014 Dec;8(8):1495-507
pubmed: 24962792
J Thorac Oncol. 2015 Dec;10(12):1670-4
pubmed: 26565381
Cell. 1991 May 31;65(5):885-93
pubmed: 1710174
J Clin Invest. 2005 Mar;115(3):653-63
pubmed: 15765148
J Transl Med. 2016 Dec 14;14(1):339
pubmed: 27974047
Cancer Discov. 2015 Oct;5(10):1049-57
pubmed: 26216294
Am J Surg Pathol. 2016 Aug;40(8):1051-61
pubmed: 27259007
Oncogene. 1989 Dec;4(12):1457-62
pubmed: 2594368
Am J Surg Pathol. 2017 Nov;41(11):1547-1551
pubmed: 28719467
JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):91-93
pubmed: 30419133
Acta Neuropathol. 2018 Aug;136(2):239-253
pubmed: 29766299
Cancer Cell. 2002 Nov;2(5):367-76
pubmed: 12450792
Nat Commun. 2015 Apr 30;6:7002
pubmed: 25926053
Cancer Discov. 2016 Jan;6(1):36-44
pubmed: 26546295
Oncologist. 2014 Mar;19(3):235-42
pubmed: 24563076
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000471
pubmed: 27148571
Neuron. 1993 Feb;10(2):137-49
pubmed: 7679912
Cell. 1991 Jul 26;66(2):395-403
pubmed: 1649702
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Cancer. 2014 Mar 15;120(6):799-807
pubmed: 24327398
EMBO J. 1996 Jul 1;15(13):3332-7
pubmed: 8670834
Am J Surg Pathol. 2016 Oct;40(10):1407-16
pubmed: 27259011
Biochim Biophys Acta. 1991 Dec 10;1072(2-3):115-27
pubmed: 1751544
Cell. 1993 Oct 8;75(1):113-22
pubmed: 8402890
Mod Pathol. 2019 Aug 2;:null
pubmed: 31375766
Nature. 1986 Feb 27-Mar 5;319(6056):743-8
pubmed: 2869410
Annu Rev Biochem. 2003;72:609-42
pubmed: 12676795
J Natl Cancer Inst. 2015 Nov 12;108(1):null
pubmed: 26563355
Ann Oncol. 2019 Feb 1;30(2):325-331
pubmed: 30624546
Proc Natl Acad Sci U S A. 1954 Oct;40(10):1014-8
pubmed: 16589582
Genomics. 1995 Jul 1;28(1):15-24
pubmed: 7590742
Nat Genet. 1996 Aug;13(4):485-8
pubmed: 8696348
Oncologist. 2016 Nov;21(11):1306-1314
pubmed: 27682134
ESMO Open. 2016 Mar 18;1(2):e000023
pubmed: 27843590
Nat Commun. 2014 Sep 10;5:4846
pubmed: 25204415
Endocrinology. 1996 Jan;137(1):198-209
pubmed: 8536613
Nat Neurosci. 2003 Jul;6(7):736-42
pubmed: 12796784
Nature. 1991 Mar 14;350(6314):158-60
pubmed: 1706478
Am J Surg Pathol. 2010 May;34(5):599-608
pubmed: 20410810
Genes Chromosomes Cancer. 2015 Nov;54(11):681-91
pubmed: 26227178
Cancer Discov. 2015 Jan;5(1):25-34
pubmed: 25527197
Development. 2004 Oct;131(20):5185-95
pubmed: 15459109
Mayo Clin Proc. 2008 May;83(5):584-94
pubmed: 18452692
JCO Precis Oncol. 2018;2018:null
pubmed: 30637364
Am J Surg Pathol. 2018 Jun;42(6):791-798
pubmed: 29553955
Pediatr Blood Cancer. 2017 Aug;64(8):null
pubmed: 28097808
Am J Pathol. 1998 Nov;153(5):1451-8
pubmed: 9811336
Cancer Discov. 2017 Sep;7(9):963-972
pubmed: 28578312
Science. 1991 Apr 26;252(5005):554-8
pubmed: 1850549
J Pathol. 2016 Apr;238(5):700-10
pubmed: 26863915
J Cell Physiol. 2000 Jan;182(1):127-33
pubmed: 10567924
Genomics. 1995 Mar 20;26(2):390-3
pubmed: 7601468
J Natl Cancer Inst. 2015 Nov 12;108(1):null
pubmed: 26563356
J Natl Cancer Inst. 2017 Dec 1;109(12):
pubmed: 29370427
J Natl Compr Canc Netw. 2017 Nov;15(11):1317-1322
pubmed: 29118225
Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1545-64
pubmed: 16939974
Am J Surg Pathol. 2017 Nov;41(11):1552-1560
pubmed: 28719468
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
Annu Rev Neurosci. 2001;24:677-736
pubmed: 11520916
Trends Cardiovasc Med. 2007 May;17(4):140-3
pubmed: 17482097
Cancer Cell. 2007 Dec;12(6):542-58
pubmed: 18068631
Cell. 1991 Sep 6;66(5):967-79
pubmed: 1653651
Eur J Hum Genet. 1997 Mar-Apr;5(2):102-4
pubmed: 9195161
Cancer Res. 2017 Jul 15;77(14):3814-3822
pubmed: 28512242
Am J Surg Pathol. 2018 Aug;42(8):1052-1058
pubmed: 29683819
Nat Rev Clin Oncol. 2017 Dec;14(12):735-748
pubmed: 28857077
J Endocrinol Invest. 1994 May;17(5):371-9
pubmed: 8077623
J Pathol. 2016 Mar;238(4):543-9
pubmed: 26606880
Nat Neurosci. 2004 Nov;7(11):1187-9
pubmed: 15494731
J Neurosci. 1997 Oct 1;17(19):7288-96
pubmed: 9295375
Acta Neuropathol. 2016 Jun;131(6):833-45
pubmed: 26810070
J Neurosci. 1996 May 15;16(10):3123-9
pubmed: 8627351
Blood. 1999 Feb 15;93(4):1355-63
pubmed: 9949179
Oncotarget. 2017 Jul 24;8(33):55353-55360
pubmed: 28903424
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766

Auteurs

A Amatu (A)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.

A Sartore-Bianchi (A)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.
Department of Oncology and Hemato- Oncology, Università degli Studi di Milano, Milan, Italy.

K Bencardino (K)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.

E G Pizzutilo (EG)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.
Department of Oncology and Hemato- Oncology, Università degli Studi di Milano, Milan, Italy.

F Tosi (F)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.
Department of Oncology and Hemato- Oncology, Università degli Studi di Milano, Milan, Italy.

S Siena (S)

Department of Hematology and Oncology, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan.
Department of Oncology and Hemato- Oncology, Università degli Studi di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH